Introduction
Lung cancer, the leading cause of cancer death in both men and women in the United States (Greenlee et al., 2001) , is a heterogeneous disease categorized as small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). The NSCLCs constitute the bulk (70 -80%) of lung cancers and are subdivided into adenocarcinomas, large cell carcinomas, and squamous cell carcinomas. Gain-of-function mutations in Ki-Ras are frequently (25 -50%) observed in adenocarcinoma and large cell carcinomas (Adjei, 2001; Graziano et al., 1999; Westra et al., 1996) and over-expression of epidermal growth factor receptor (EGFR) family members is often observed in squamous NSCLC (Hsieh et al., 2000; Nicholson et al., 2001; Ohsaki et al., 2000) . NSCLCs also exhibit frequent loss-offunction in several defined tumor suppressor genes including p53 (*50%), Rb (15 -30%) and p16
INK4
(30 -70%) (Sekido et al., 1998) . In addition, variable deletion of putative and ill-defined tumor suppressor genes residing on chromosome 3p is frequent in NSCLC (Sekido et al., 1998) . Combined, these studies indicate a large degree of heterogeneity in the molecular perturbations that lead to the development of NSCLC.
Molecular perturbations in specific components of the Wnt signaling pathway have been frequently implicated as transforming events in diverse human tumors. For example, 85% of familial human colorectal cancers have APC mutations and as many as 25% have gain-of-function b-catenin mutations (Kinzler and Vogelstein, 1996) . APC and b-catenin mutations have also been implicated in hepatocellular, breast, and uterine carcinoma, as well as melanoma (de La Coste et al., 1998; Fukuchi et al., 1998; Rimm et al., 1999) . Catenins constitute a family of cytoplasmic proteins that were first discovered as binding partners for the intracellular domain of the cell adhesion molecule uvomorulin and also serve important roles in cell-cell adhesion and cytoskeletal regulation (Ozawa et al., 1989) . g-Catenin is a structural component of both desmosomes and adherens junctions (Karnovsky and Klymkowsky, 1995) and both b-catenin and g-catenin are involved in diverse development processes (Karnovsky and Klymkowsky, 1995) . Furthermore, evidence indicates that both b-catenin and g-catenin are components of the Wnt signaling pathway as the stability of these proteins is regulated by APC (Kolligs et al., 2000) and both are able to interact with TCF (Zhurinsky et al., 2000) .
In contrast to most human cancers, there is a notable absence of definitive data on the status of the Wnt signaling pathway and either b-catenin or gcatenin in lung cancer. In fact, a recent report reveals that mutations in the genes encoding b-catenin and gcatenin are rarely observed in human lung cancer (Ueda et al., 2001) . In the present study, we demonstrate that the expression levels of g-catenin are markedly decreased in a subset of NSCLC cell lines as well as primary lung cancers. We further demonstrate that reduced expression of g-catenin in NSCLC correlates with increased TCF transcriptional activity and overexpression of g-catenin in lung cell lines with reduced levels of g-catenin lead to suppression of bcatenin/TCF activity and cell growth. Our findings thus support g-catenin as a potentially novel tumor suppressor involved in lung cancer.
Results

Analysis of b-catenin and g-catenin levels in NSCLC cell lines
Increased accumulation of b-catenin secondary to mutations in either the b-catenin or APC polypeptides as well as hyperactivity of the upstream Wnt signaling pathway is observed in several tumor cell types including colon carcinomas (de La Coste et al., 1998; Fukuchi et al., 1998; Kinzler and Vogelstein, 1996; Rimm et al., 1999) . Therefore, we measured the cellular levels of both b-catenin and g-catenin polypeptides by immunoblotting as a potential means of rapidly assessing the activity of the Wnt signaling pathway in a panel of cultured lung cancer cell lines. Figure 1a shows the protein expression of b-catenin and g-catenin in a panel of lung cancer cell lines as measured with monoclonal antibodies directed against g-catenin or bcatenin. The cellular content of b-catenin was readily detected in all of the NSCLC lines as well as BEAS2B cells, a SV40 Large T antigen-immortalized human lung epithelia cell line. In fact, the expression of bcatenin was equivalent to that observed in the colon carcinoma cell line, SW480 (data not shown), which bears a loss-of-function APC mutation and leads to bcatenin accumulation (Morin et al., 1997) . By contrast, variable expression of g-catenin was observed in the panel of lung cancer cell lines (Figure 1a) . The NSCLC lines H157, H226 and H1703 expressed little or no gcatenin expression and decreased g-catenin expression was observed in H520 cells. A uniformly high g-catenin expression was observed in the remaining five NSCLC lines tested. Thus, the findings reveal no evidence of increased cellular b-catenin accumulation in any of the NSCLC lines relative to BEAS2B, but rather an unexpected lack of g-catenin expression in some of these cell lines. Fractionation of BEAS2B, A549 and H157 cells into cytoplasmic and nuclear fractions indicated that the bulk of g-catenin was present in the cytosolic fractions (Figure 1b ). However, a significant amount of g-catenin was also detected in the nuclear fractions of BEAS2B and A549 cells, but not in H157 cells.
DNA methylation is a common mechanism for gene silencing in cancer cells where DNA methylation in CpG islands located in gene promoter regions leads to the recruitment of histone deacetylase (HDAC) and chromatin condensation (Soengas et al., 2001) . As shown in Figure 1c , the content of g-catenin markedly increased in H157 and H1703 cells treated with 5aza2dC or trichostatin A. By contrast, no significant change was observed in g-catenin content in A549 or BEAS2B cells treated with 5aza2dC or trichostatin A. Moreover, the cellular content of b-catenin did not Figure 1 Immunoblot analysis of the cellular content of b-catenin and g-catenin in NSCLC cell lines. (a) Extracts were prepared from the indicated cancer cell lines and the non-transformed BEAS2B cells with MAPK lysis buffer. Aliquots containing 100 mg protein were resolved on 10% polyacrylamide SDS gels, transferred to nitrocellulose and probed with monoclonal antibodies specific for b-catenin and g-catenin. (b) The indicated cell lines were fractionated into cytoplasmic (cyto) and nuclear (nuc) components as described in the Materials and methods. Aliquots containing 10 mg protein were resolved by SDS -PAGE and immunoblotted for g-catenin or lamin, a marker of the nuclear fraction. (c) The indicated NSCLC cell lines and BEAS2B cells were incubated for 1 day with 300 ng/ml trichostatin A (TSA) or for 3 days with 3 mM 5aza2dC. Extracts were prepared as in a and immunoblotted for g-catenin and b-catenin g-Catenin expression in lung cancer RA Winn et al change following treatment of any of the NSCLC cell lines with these inhibitors (data not shown). This experiment suggests that the low g-catenin expression observed in H157 cells results from DNA methylationdependent suppression of g-catenin gene expression. Consistent with this possibility, a recent report invoked DNA methylation as a mechanism for decreased gcatenin in several thyroid carcinoma cell lines (Potter et al., 2001) .
To confirm the findings of reduced expression of gcatenin in NSCLC cell lines as measured by immunoblot analysis, we performed immunofluorescence staining with monoclonal antibodies against g-catenin and b-catenin. As shown in Figure 2 , strong staining for both b-catenin and g-catenin was observed in BEAS2B cells. The cytoplasm stained diffusely with more concentrated staining at the plasma membrane. The nuclei clearly did not exclude g-catenin, consistent with the presence of g-catenin in nuclear fractions of BEAS2B and A549 cells (Figure 1b) . By contrast, both H157 and H1703 cells stained positively for b-catenin, but negligibly for g-catenin (Figure 2 ). These results demonstrate that the failure to detect g-catenin in certain NSCLC cell lines by immunoblot analysis is not due to retention of the g-catenin protein in a cellular compartment which is not efficiently extracted by the cell lysis buffer used in the experiments shown in Figure 1 .
Reduced expression of g-catenin in a subset of primary NSCLC tumors
To determine if reduced g-catenin expression is also observed in primary lung cancer tissues, immunohistochemical analysis of a panel of 120 NSCLC tumor specimens representing both adenocarcinomas and squamous cell carcinoma subtypes was performed. Figure 3a shows that g-catenin is readily detected in bronchial epithelial cells, but not in mesenchymal cells, of a normal human lung specimen. In addition, a representative lung cancer specimen exhibiting intense staining for g-catenin ( Figure 3b ) and one specimen that stained negatively for g-catenin (Figure 3c ) is shown. When a panel of 120 primary NSCLC specimens was similarly analysed, a heterogeneous pattern of g-catenin staining was observed with *30% of the primary NSCLC tumors showing negative to weak staining for g-catenin ( Figure 3d ). By contrast, only *5% of the NSCLC tumors showed trace to weak staining for b-catenin and no tumors stained nega- Figure 2 Immunofluorescence analysis of b-catenin and g-catenin in H157, H1703 and BEAS2B cells. The NSCLC cell lines H157 and H1703 which express little or no g-catenin (see Figure 1a ) and BEAS2B cells which expresses both g-catenin and b-catenin were fixed and stained as described in Materials and methods with monoclonal antibodies against b-catenin or g-catenin. The monoclonal antibodies were visualized with FITC-goat anti-mouse IgG and inspected with a fluorescence microscope tively. Interestingly, weak or negligible g-catenin expression was observed as frequently in adenocarcinomas as in squamous cancers. Among the cultured NSCLC lines, however, all the low/negative g-catenin expressing cells were squamous NSCLC lines. Overall, these data are consistent with our findings in Figures 1 and 2 and indicate that reduced or negligible g-catenin expression occurs in primary tumor samples and is not restricted to NSCLC cell lines that have adapted for in vitro growth.
Elevated basal TCF activity in cell lines with low endogenous g-catenin
While one defined activity of b-catenin within cells is a co-activator for the transcription factor TCF, the activity of g-catenin within cells is less well understood. Indeed, g-catenin has been invoked as an additional coactivator molecule with TCF as well as an inhibitor of TCF function (Kolligs et al., 2000; Parker et al., 1998; Sadot et al., 1998) . To measure the functional activity of b-catenin/TCF complexes in the NSCLC cell lines expressing different levels of g-catenin, a luciferase reporter controlled by tandomized TCF-binding sites (referred to as TOPFLASH) was transfected into NSCLC cells by electroporation. The transfections were performed in the absence or presence of a plasmid encoding a dominant-negative TCF polypeptide to define the reporter activity specifically dependent on TCF (Tetsu and McCormick, 1999) . As shown in Figure 4 , a BEAS2B cells and NSCLC lines A549 and H2122 had low basal dnTCF-inhibitable TOPFLASH activity. Co-transfection of a b-catenin construct rendered constitutive-active an in-frame Nterminal deletion of amino acids 29 -48 stimulated TOPFLASH reporter activity by 48-fold averaged over several experiments, verifying that the reporter was sensitive to b-catenin/TCF complexes in these cells Figure 3 Reduced or negligible expression of g-catenin is observed in a significant percentage of primary NSCLC specimens. (a) Normal human bronchiolar epithelium stained for g-catenin. Two representative primary human NSCLCs from the tissue array, one of which stained strongly for g-catenin (b) and another which stained negatively for g-catenin (c). The tumor sections were stained and scored as described in the Materials and methods. The tumor specimen in (b) was scored as 400 while the tumor specimen in (c) was scored as 0. (d) The staining intensities of g-catenin and b-catenin in the tumor samples were scored as described in the Materials and methods where tumor specimens with an overall score of 0 -100, 101 -200, and 201 -400 were classified as having negligible to trace, low, and intermediate to high level expression, respectively. Approximately 30% of the tumors stained within the negligible to trace and low expression categories for g-catenin while *5% of the tumors stained similarly for b-catenin (data not shown). By contrast, H157 and H1703 NSCLC cell lines which expressed low levels of gcatenin (Figure 1 ) exhibited markedly elevated TOPFLASH activity that was largely inhibited by dnTCF. Thus, these experiments indicate the H157 and H1703 lung cancer cell lines which have low g-catenin levels also have elevated TCF activity.
Re-expression of g-catenin constructs specifically reduces b-catenin/TCF activity and growth in NSCLC cell lines with low levels of g-catenin
The experiment in Figure 4 suggests that g-catenin may, in fact, function as a suppressor of b-catenin/ TCF activity in lung cancer cell lines and loss of expression of the g-catenin protein results in elevated bcatenin/TCF activity. To test this possibility, H1703 cells were transfected with the TOPFLASH reporter along with increasing amounts of an expression plasmid encoding g-catenin. As shown in Figure 5 , co-transfection of increasing amounts of g-catenin plasmid resulted in an 85% reduction in TOPFLASH activity. Moreover, co-transfection of g-catenin reduced by 80% the increased TOPFLASH reporter activity elicited by gain-of-function b-catenin (Tetsu and McCormick, 1999) in BEAS2B cells ( Figure 5 ). By contrast, transfection of A549 cells with g-catenin stimulated TOPFLASH activity *fivefold, indicating that the inhibition of TOPFLASH activity by g-catenin expression in H1703 cells is not simply a result of Increasing amounts of a plasmid encoding wild-type g-catenin was co-transfected into H1703 cells with the TOPFLASH reporter by electroporation as described in Materials and methods. The cells were cultured for 2 days, extracts were prepared and assayed for luciferase and b-galactosidase activities where co-transfected CMV-bGal served as an internal control for transfection efficiency. The results are presented as the percentage of the reporter activity measured in cells transfected with empty pCDNA3 and are the mean and s.e.m. of three independent experiments. (b) BEAS2B cells were co-transfected with 2 mg of pCDNA3 or pCDNA3-constitutive-active b-catenin (CA-b-catenin) and increasing amounts of g-catenin expression plasmid as indicated. Two days later, extracts were prepared and assayed for luciferase and b-galactosidase activities. The results are from one experiment that is representative of two other independent experiments competition for transcriptional co-activator secondary to g-catenin. These data indicate that g-catenin can function as an inhibitor of b-catenin/TCF signaling in lung epithelial cells and NSCLC cells.
To evaluate the role of g-catenin on cell growth, we employed retrovirus-mediated gene transfer to stably express a g-catenin cDNA in A549 cells which express significant amounts of g-catenin protein as well as H157 cells which express low levels of g-catenin protein. Despite repeated attempts, we were unable to successfully transduce the H1703 cells which also expressed very low g-catenin levels. Figure 6 shows immunoblots of cell extracts prepared from A549 and H157 cells stably transduced with the empty LNCX2 vector or LNCX2-g-catenin. The filters were probed with the monoclonal antibody directed against the gcatenin polypeptide to assess the relative levels of exogenous and endogenous levels of the protein. As shown in Figure 6 , the exogenously-expressed g-catenin polypeptide migrated more slowly by SDS -PAGE due to the FLAG epitope incorporated at the C-terminus. Thus, the anti-g-catenin blot indicates that exogenous g-catenin was successfully transduced into H157 and A549 cells. Of note, a parallel immunoblot for bcatenin revealed that re-introduction of g-catenin had no significant effect on endogenous b-catenin levels ( Figure 6 ).
Having demonstrated that the g-catenin expression vector was expressed in the H157 and A549 cells, we assessed the influence on the growth properties of the cells. Cell growth measured on standard tissue culture plastic in complete medium revealed that g-catenin reexpression in H157 cells reduced the doubling time of these cells *2 -3-fold relative to the empty vector controls (Figure 7) . By contrast, the growth rate of A549 cells over-expressing g-catenin were not different from the LNCX2 vector controls (Figure 7) . Moreover, a more dramatic inhibition of anchorage-independent growth of the H157 cells expressing ectopic g-catenin was observed where anchorage-independent cell growth in soft agar-containing medium is a more stringent criterion of the transformed phenotype of cultured tumor cells. The soft agar cloning efficiency of H157 -LNCX2 cells was 36+1% while the H157-g-catenin cells cloned with an efficiency of only 7+2%. By contrast, A549 -LNCX2 cells and A549-g-catenin cells cloned with efficiencies of 17+1% and 23+2%, respectively. Thus, re-introduction of g-catenin into H157 cells which express little or no endogenous gcatenin strongly inhibited cell growth, indicating that gcatenin fulfills a key criterion of a tumor suppressor.
Discussion
The results presented in this study reveal reduced or absent expression of g-catenin in a subset of primary human lung tumors and cultured NSCLC cell lines. The increased expression of g-catenin in H157 and H1703 cells following treatment of the cells with inhibitors of DNA methylation or histone deacetylase suggests that g-catenin expression is inhibited in these instances through a DNA methylation-dependent mechanism (Figure 1) . Alternatively, DNA methylation may silence a gene encoding a transcription factor required for g-catenin expression. Significantly, our novel demonstration that exogenously expressed gcatenin inhibits b-catenin/TCF-dependent transcriptional activity and in vitro growth of g-cateninnegative, but not g-catenin-positive NSCLC cell lines fulfills a key criterion for supporting g-catenin's role as a tumor suppressor in a specific population of lung tumors. Consistent with a tumor suppressor role for gcatenin, Simcha et al. (1996) have previously noted that over-expression of g-catenin suppressed the tumorigenicity of SV40-transformed 3T3 cells. Also, transfection of g-catenin into SCC9 squamous cell carcinoma cells which do not express endogenous gcatenin stimulated epidermoid-like differentiation accompanied by desmosome formation, decreased growth rate and increased matrix adhesiveness (Parker et al., 1998) . By contrast, g-catenin transfection of RK3E E1A-transformed rat kidney epithelial cells induced neoplastic transformation (Kolligs et al., 2000) . While the level of endogenous g-catenin in RK3E cells was not shown, it is likely that the function of g-catenin with regard to cell growth will be dependent on the specific cellular context. Among the family of catenin proteins including acatenin, b-catenin and g-catenin, b-catenin has Figure 6 Retrovirus-mediated gene expression of g-catenin in NSCLC cell lines. Retroviruses encoding empty LNCX2 or LNCX2-g-catenin were used to transduce NSCLC cell lines H157 and A549 as described in the Materials and methods. Extracts were prepared from the pooled G418-resistant cultures with MAPK lysis buffer and aliquots containing 100 mg protein were resolved on 10% polyacrylamide SDS gels, transferred to nitrocellulose and probed with antibodies to g-catenin or b-catenin. The transfected g-catenin cDNA encodes a C-terminal FLAG epitope which results in the slower migration of the transduced g-catenin polypeptide relative to endogenous g-catenin. Replicate filters were immunoblotted for b-catenin which does not change in content following expression of g-catenin g-Catenin expression in lung cancer RA Winn et al attracted considerable attention for a dominant transforming role in diverse human cancers including colon cancer (de La Coste et al., 1998; Fukuchi et al., 1998; Rimm et al., 1999) . In these settings, accumulation of b-catenin protein secondary to inhibition of its degradation leads to nuclear translocation where the protein serves as a co-activator with the TCF/LEF family of transcription factors (Polakis, 2000) . No evidence exists to support a similar role for b-catenin in lung cancers. In fact, a NSCLC cell line has been identified in which the b-catenin gene is homozygously disrupted (Calvo et al., 2000) . While this appears to be a rather rare event in lung cancers, we show in the present study that reduced or negligible expression of g-catenin is a relatively frequent occurrence in cultured NSCLC cells as well as in *30% of primary lung tumors (Figures 1 and 3 ). Our findings in this regard are consistent with other studies noting reduced expression of g-catenin in primary lung tumors (Pantel et al., 1998; Pirinen et al., 2001; Toyoyama et al., 1999) . In preliminary studies, we have found that reduced tumor expression of g-catenin correlates with poorer tumor differentiation and increased lymph node metastasis and is significantly associated with reduced patient survival (Bremnes RM and Franklin WA, submitted). Other laboratories have also observed reduced expression of g-catenin in NSCLC specimens and noted a correlation with high cell proliferative activity and poor differentiation (Pantel et al., 1998; Pirinen et al., 2001; Toyoyama et al., 1999) . Thus, our studies and others demonstrate a frequent loss of gcatenin expression in lung tumors that is correlated with a more aggressive phenotype in vivo.
Using NSCLC cell lines, we demonstrate that reduced levels of g-catenin are associated with increased basal TCF activity as measured with a TCF/LEF-dependent reporter (Figure 4) . Importantly, gene transfer-mediated expression of g-catenin with mammalian expression vectors inhibited the increased TCF activity ( Figure 5 ) as well as transformed cell growth (Figure 7 and text) . Thus, our findings point to a role for g-catenin as a suppressor of b-catenin/TCF action in the nucleus. Consistent with the findings in our study, g-catenin has been shown to play a role in the down-regulation and decreased stability of intracellular b-catenin in cancers (Pantel et al., 1998; Parker et al., 1998; Pirinen et al., 2001; Toyoyama et al., 1999) . Our studies do not support de-stabilization of bcatenin as a mechanism by which g-catenin reexpression inhibits b-catenin/TCF activity as b-catenin is equivalently expressed in NSCLC cell with high or low g-catenin content (Figure 1) . Also, b-catenin levels do not decrease in H157 cells transduced with a retrovirus encoding g-catenin (Figure 6 ) or in H157 and H1703 cells treated with trichostatin or 5aza2dC (Figure 1) . Interestingly, g-catenin has been shown to stably bind to TCF within cells (Huber et al., 1996) , although formation of ternary g-catenin/TCF-DNA complexes is very inefficient (Zhurinsky et al., 2000) . It has been recently shown that b-catenin and g-catenin interact with different sites on TCF-4 and the interaction of g-catenin hinders the transcriptional activity of b-catenin/TCF (Miravet et al., 2002) . Based on these findings, it is possible that transfected gcatenin may sequester TCF within the nucleus and disrupt the formation of functional b-catenin/TCF complexes in a non or uncompetitive manner.
Based on our results, we hypothesize that g-catenin functions as a tumor suppressor in some human lung cancers, perhaps as much as 30%, by serving as a negative regulator of b-catenin/TCF in the nucleus. In colon carcinomas, some of the target genes that are regulated through b-catenin/TCF have been identified and include c-myc (He et al., 1998) , cyclo-oxygenase-2 (Howe et al., 2001) , cyclin D (Shtutman et al., 1999; Tetsu and McCormick, 1999) , matrix metalloproteinase Figure 7 Re-expression of g-catenin in H157 NSCLC cells inhibits growth. The indicated H157 or A549 transfectants were seeded in 24-well plates and growth curves were generated as described in the Materials and methods. The results are the mean and s.e.m. of three independent experiments g-Catenin expression in lung cancer RA Winn et al 7 (Brabletz et al., 1999; Crawford et al., 1999) , and WISP (Pennica et al., 1998) . Experiments are presently ongoing to define gene expression changes in NSCLC cells associated with retrovirus-mediated re-expression of g-catenin. These studies are likely to further define the function of g-catenin in normal and transformed lung epithelia.
Materials and methods
Cell culture
BEAS2B, an SV40 large T-immortalized human lung epithelial cell, and NCI NSCLC cell lines H157, H226, H520, H1703, H2122, H1650, H1693, H1869 and A549 were grown in RPMI supplemented with 10% fetal bovine serum (FBS) and incubated at 378C in an humidified 5% CO 2 incubator.
Transient transfection and reporter assays
Aliquots of lung cancer cells (2 million cells in 100 ml) were electroporated (220 volts and 250 mF with a geneZAPPER (IBI, New Haven, CT, USA) in Gene Pulser 0.4 cm electrode gap cuvettes (Bio Rad, Hercules, CA, USA). Cells were transfected with 2 mg TOPFLASH and 1 mg pCMV-bGal for determination of transfection efficiency and other expression plasmids as indicated in the figure legends. Following electroporation, cells were plated in 10 cm dishes in full media. After 3 days of incubation, the cells were collected, washed once with ice-cold phosphate-buffered saline (PBS) and resuspended in 250 ml of Luciferase Reporter Lysis Buffer (Promega). The cell lysates were centrifuged in a microcentrifuge and aliquots (80 ml) of the supernatants assayed for luciferase activity with a Monolight 2010 luminometer (Analytical Luminescence Laboratory, Ann Arbor, MI, USA) and luciferase assay substrate from Promega. Aliquots (15 ml) of the extracts were also assayed for b-galactosidase (bGal) to correct for transfection efficiency. The data are presented as relative light units (RLU) per milliunit b-galactosidase (RLU/mU bGal).
Retroviral-mediated gene transfer
A cDNA encoding g-catenin with a FLAG epitope encoded at the C-terminus inserted in pCDNA3 was kindly provided by Dr Eric Fearon (University of Michigan Health System, Department of Internal Medicine, MI, USA). The g-catenin cDNA was excised from pCDNA3 with HindIII and NotI and ligated between the HindIII and NotI sites of the retroviral expression vector, pLNCX2 (Clontech Laboratories, Inc., Palo Alto, CA, USA). The resulting vector, LNCX2-g-catenin, was packaged into replication-defective retrovirus using 293T cells and the retrovirus-component expression plasmids SV-C 7 A-MLV and SV-C 7 env 7 MLV as described (Beekman et al., 1998; Landau and Littman, 1992; Pear et al., 1993) . The secreted LNCX2-g-catenin retroviruses as well as empty LNCX2 viruses were collected and used to transduce NSCLC cells lines H157 and A549. The transduced cells were selected in growth medium containing G-418 (250 mg/ml) and maintained as pooled cultures of G-418-resistant cells.
For the measurement of transfected cell growth on plastic dishes, 50 000 cells of the different transfectants were seeded per well in full growth medium in replicate wells of a 24-well plate. On subsequent days as indicated, the cells were trypsinized from wells with 100 ml of trypsin, diluted with 400 ml growth medium and counted with a hemocytometer. For measurement of anchorage-independent cell growth, 5000 cells were plated in triplicate in 35 mm wells of a six-well plate in a volume of 1.5 ml of growth medium containing 0.3% nobel agar onto a base of 1.5 ml growth medium containing 0.5% agar. The plates were incubated in a 378C CO 2 incubator for 21 days and the colonies were counted with a microscope. The data are presented as cloning efficiency calculated by dividing the mean number of colonies per well by the number of cells (5000) plated.
Immunoblot analysis
Samples of cell extracts prepared in MAP kinase lysis buffer (0.5% Triton X-100, 50 mM b-glycerophosphate (pH 7.2), 0.1 mM sodium vanadate, 2 mM MgCl 2 , 1 mM EGTA, 1 mM DTT, 2 mg/ml leupeptin and 4 mg/ml aprotinin) were resolved by 10% SDS -PAGE and transferred to nitrocellulose. Nuclear and cytoplasmic fractions were prepared by an adaptation of the methods of Bates et al. (1994) . Briefly, lung cell lines A549, BEAS2B, and H157 were grown to confluency in 100 mm tissue culture plates, washed once with phosphate buffered saline, collected in nuclear extraction buffer (10 mM NaCl, 10 mM Tris-Cl pH 7.5, 3 mM MgCl 2 ) and subjected to dounce homogenization (10 strokes). Homogenized cell lysates were then placed over a solution of nuclear extraction buffer containing 30% sucrose. Low speed centrifugation for 5 -10 min allowed accumulation of nuclear pellet and a cytoplasmic fraction above the sucrose layer. Nuclear pellets were washed three times with nuclear extraction buffer prior to resuspension in 100 ml of nuclear extraction buffer. To confirm that cytoplasmic fractions were clear of nuclear contamination, duplicate westerns were probed for lamin A and C (antibody MMS-107R, Babco, Richmond, CA, USA) and g-catenin (antibody C26220, Transduction Laboratories, Lexington, KY, USA).
The filters were blocked in Tris-buffered saline (10 mM Tris-Cl, pH 7.4, 140 mM NaCl) containing 0.1% Tween-20 (TTBS) and 3% nonfat dry milk and then incubated with the same blocking solution containing the indicated antibodies at 1 mg/ml for 12 -16 h. The filters were extensively washed in TTBS and bound antibodies were visualized with alkaline phosphatase-coupled secondary antibodies and LumiPhos reagent (Pierce, Rockford, IL, USA) according to the manufacturer's directions.
Immunofluorescence BEASZB, H157, H1703, and A549 were grown on glass cover slips in RPMI growth media for 24 h at 378C. After three washes with phosphate buffered saline (PBS), cells were fixed with a 1 : 1 mixture of methanol : acetone at 7208C for 10 min, then blocked with 1% bovine serum albumin (BSA)/ Hank's balanced salt solution (HBSS) for 10 min prior to incubation with the primary antibodies. The slides were then incubated at room temperature for 1 h with the monoclonal antibodies against b-or g-catenin 1 : 100 dilution. The slides were extensively washed and incubated for 30 min with a secondary goat anti-mouse IgG-FITC antibody 1 : 500 dilution. The slides were washed with 1% BSA/HBSS and the cover slips were mounted on glass microscope slides using fluoromount G. Finally, the slides were examined with fluorescence optics on an Olympus microscope, and photographed at a 4006 magnification.
Immunohistochemistry
Primary tumor tissue samples (60 squamous cell carcinomas, 60 adenocarcinomas) were obtained from patients diagnosed with non-small cell lung cancer pathological stage I-III at the University of Colorado Cancer Center (UCCC). In cases where surgical resection of the lung tumor was not performed, examinations were carried out on lymph node tissue from mediastinoscopy (n=11). The protocols for obtaining these human tissues were approved by the Colorado Institutional Review Board (COMIRB). Formalin-fixed and paraffin-embedded tumor specimens were sectioned at 4 mm with a Leitz microtome, deparaffinized with standard xylene and hydrated through graded alcohols into water. Antigen retrieval was performed in citrate buffer using a Biocare Medical decloaking chamber (Biocare Medical, Walnut Creek, CA, USA). Peroxide blocking was preformed with 3% peroxide in absolute methanol (BioTEK Solutions Inc). Blocking was performed at room temperature with Avidin Biotin block (DAKO, Carpineteria, CA, USA) followed by Power Block (BioGenex, San Ramon, CA, USA) for b-catenin and with Powerblock only for g-catenin.
Mouse monoclonal anti b-catenin (clone 14, Transduction Laboratories, Lexington, KY, USA) was applied at a 1 : 100 dilution and mouse monoclonal anti-g-catenin (clone 15, Transduction Laboratories, Lexington, KY, USA) was applied at a 1 : 50 dilution. Following incubation of primary antibodies for 1 h at 378C, the secondary antibody DAKO Biotinylated Multi-Link anti-mouse, goat, and rabbit Ig with 40% human serum was applied for 30 min at room temperature. This was followed by application of streptavidin HRP enzyme complex (DAKO, Carpineteria, CA, USA) and DAB chromogen (DAKO, Carpineteria, CA, USA). The slides were then counterstained in hematoxylin and coverslips were mounted.
By light microscopy, the tissue sections were scored semi quantitatively based on the percentage of positive tumor cells per slide (0 -100%) multiplied by the dominating intensity of the membrane/cytoplasm staining (0=negative, 1=trace, 2=weak, 3=moderate, 4=intense) to generate an overall score that ranged from 0 -400. Specimens with an overall score of 0 -100, 101 -200, 201 -300 and 301 -400 were classified as having trace, low, intermediate, and high level expression, respectively. Specimens that exhibited complete absence of staining or faint staining in less than 5% of the cells were classified as negative. The specimens were viewed by two independent investigators and scored without knowledge of the case histories. The scores from each investigator were compared for interobserver reliability by use of a twoway random effect model with absolute agreement definition and a correlation coefficient of 0.96 was determined, indicating excellent reproducibility of the scores between the observers.
